GenieFluor Violet 450 Anti-Human HLA-A,B,C Antibody [W6/32]
- SKU:
- AGEL3363
- Product Type:
- Antibody
- Antibody Type:
- Monoclonal Antibody
- Applications:
- FCM
- Reactivity:
- Human
- Host Species:
- Mouse
- Isotype:
- Mouse IgG2a, k
- Clone:
- W6/32
- Conjugation:
- AFViolet 450
Description
Product Name: | AFViolet 450 Anti-Human HLA-A,B,C Antibody [W6/32] |
Product Code: | AGEL3363 |
Size: | 20 Tests, 100 Tests, 200 Tests |
Clone No: | W6/32 |
Synonyms: | Major Histocompatibility Class I, MHC class I |
Reactivity: | Human |
Host Species: | Mouse |
Applications: | FCM |
Isotype: | Mouse IgG2a, κ |
Isotype Control: | EV450 Mouse IgG1, κ Isotype Control [MOPC-21] |
Conjugation: | AFViolet 450 |
Applications: | FCM |
Recommended Dilution: | Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
Storage Buffer: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
Storage: | Keep as concentrated solution. Store at 2-8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase. |
Fluorescent Label: | GenieFluor Violet 450 is designed to be excited by the violet laser (405 nm) and detected using an optical filter centered near 450 nm (e.g., a 450/45 nm bandpass filter). |
Shipping: | Biological ice pack at 4°C |
Form: | Liquid |
Gene ID: | 3105 |
Swissprot: | P04439,P01889,P10321 |
Background Information: | MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance. |